Contraception

Do age, race, or other demographics influence postpartum IUD compliance? The results of this retrospective chart review were presented at ACOG's Annual Clinical Meeting.

Typically used for long-term contraception, the intrauterine device (IUD) is also an effective emergency contraceptive if implanted after unprotected sex. Two IUDs, which are T-shaped pieces of plastic, are available in the United States.

When used under routine conditions, vaginal ring and combined oral contraceptives have similar venous thrombolism risks, according to a prospective, controlled, non-interventional cohort study.

Providers underestimate the intensity of patients’ pain during IUD insertion, and often misidentify the moment at which maximum pain occurs, according to a randomized trial of 200 women. Midlevel providers are slightly better at estimating pain intensity.

A recent study shows that health care professionals continue to have misconceptions about the safety of IUDs for nulliparous women.

Poll shows ob/gyn opinions are split on the federal mandate that private insurance plans cover the cost of birth control.

Should employers be required to provide insurance that includes free contraceptive coverage?

Ulipristal is a safe and effective option for women with uterine fibroids, according to two new studies published in the New England Journal of Medicine. In both studies, the oral selective progesterone receptor modulator was well-tolerated, rapidly reduced excessive bleeding, and decreased the size of uterine fibroids.

Oral contraceptives have long been considered an option for relieving symptoms of dysmenorrhea, but a 2009 Cochrane review cast doubt on that claim. Now, a new study out of Sweden offers contradictory evidence.

William Parker, MD discusses the use of MRI in diagnosing and managing uterine fibroids. Dr. Parker's upcoming Clinical Opinion article, “The utility of MRI for the surgical treatment of women with uterine fibroid tumors”, will be published in the American Journal of Obstetrics and Gynecology in 2012.

OBGYN.net Conference Coveragefrom the 18th Annual Meeting of ESHRE - Vienna, Austria

OBGYN.net Conference CoverageFrom the ESHRE 2001 Conference - Lausanne, Switzerland

Yeast infections are one of the most common infections occurring in women. Although they are rarely dangerous, they can be very bothersome and uncomfortable.

With its implications of sexual transmission and potential cervical cancer, a diagnosis of genital warts can be emotionally distressing to patients. Because no single treatment serves every patient, the best approach to selecting a therapeutic option considers the extent of the disease, wart location, and the patient's individual needs.

Diagnosis, Transmission, and Management

One out of four Americans between 15 and 55 will catch at least one sexually transmitted infection (STI).

Although genital herpes is common there are a lot of misperceptions about this sexually transmitted infection. Genital herpes is caused by a virus, called Herpes Simplex Virus, or "HSV" for short.

Pelvic Inflammatory Disease, or PID, is an infectious disease that affects millions of U.S. women and girls each year. Although usually surprisingly easy to treat, it can be hard to diagnose, and can lead to many long-term and troublesome complications.

October: National Family Sexuality Education Month

This KIDS COUNT Special Report contains some hopeful news for the future of America's families. Since 1991, the percentages of American teenagers getting pregnant, giving birth, or having abortions have all fallen.

Vulvodynia is a medical term that means "painful vulva". The term can cover a wide variety of vulvar pain syndromes, including various infections and skin disorders.

And my task for this afternoon is to review for you a new contraceptive option and what I’d like to do first is show you my disclosure statement and then I will go into the first part of discussion, talk about why I think there’s a need for this new contraception option and then go in much greater depth in discussing it.

“We just heard a presentation about one of the several new devices for contraception and you took part in a lot of research about this Transdermal Patches for contraception.

Good afternoon, everyone. Thank you, Ron. These are truly exciting times for us in providing contraception and healthcare to women, but with that excitement comes some responsibility.

think it’s important to start with why we need new. When it’s I think clear for many of our subscribers and many clinicians that the methods that we already have are very effective, that despite having very effective methods, throughout Europe, United States and around the world we are still met with very high rates of unintended pregnancy.